epimedium
flavonoid
inhibit
extravascular
lipid
deposit
prevent
steroidassoci
osteonecrosi
desmethylicaritin
bioactiv
metabolit
epimedium
flavonoid
serum
well
known
estrogen
inhibit
aidpogenesi
hypothes
desmethylicaritin
phytoestrogen
might
potenti
inhibit
lipid
deposit
studi
design
investig
effect
desmethylicaritin
adipogenesi
underli
mechan
vitro
adipogenesi
assess
oil
red
stain
preadipocyt
bromodeoxyuridin
use
test
clonal
expans
mrna
level
protein
express
adipgen
relat
factor
detect
qrtpcr
western
blot
respect
nuclear
locat
identifi
use
immunofluores
assay
result
show
desmethylicaritin
suppress
adipogenesi
cell
dosedepend
manner
addit
desmethylicaritin
inhibit
clonal
expans
adipogenesi
desmethylicaritin
affect
ccaatenhanc
bind
protein
mrna
express
decreas
mrna
express
ccaatenhanc
bind
protein
peroxisom
proliferatoractiv
receptor
adipocyt
lipidbind
protein
lipoprotein
lipas
desmethylicaritin
upregul
mrna
express
howev
downregul
adipogen
induct
desmethylicaritin
increas
protein
express
cytoplasm
nuclei
immunofluoresc
result
confirm
desmethylicaritin
increas
nuclear
transloc
find
impli
desmethylicaritin
abl
inhibit
adipogenesi
signal
pathway
regul
desmethylicaritin
process
suppress
adipogenesi
find
support
desmethylicaritin
novel
phytochem
agent
potenti
prevent
disord
involv
lipid
metabol
puls
corticosteroid
frequent
prescrib
lifesav
agent
seriou
infecti
diseas
sever
acut
respiratori
syndrom
chronic
autoimmun
diseas
howev
steroidassoci
osteonecrosi
frequent
occur
result
highdos
corticosteroid
treatment
extravascular
lipiddeposit
major
consent
etiopathogenesi
steroidassoci
osteonecrosi
lieberman
et
al
experiment
confirm
lipidlow
agent
abl
prevent
steroidassoci
osteonecrosi
motomura
et
al
epimediumderiv
flavonoid
shown
benefici
effect
prevent
steroidassoci
osteonecrosi
inhibit
extravascular
lipiddeposit
previou
experiment
studi
qin
et
al
zhang
et
al
zhang
et
al
howev
underli
mechan
epimediumderiv
flavonoid
inhibit
adipogenesi
remain
unknown
cell
line
one
wellcharacter
reliabl
vitro
model
studi
convers
preadipocyt
adipocyt
lee
et
al
adipocyt
differenti
involv
sequenti
activ
variou
transcript
factor
lane
rosen
macdougald
cebpd
cebpb
earliest
transcript
factor
induc
adipogen
stimuli
transcript
activ
cebpa
pparg
gene
cebp
regulatori
element
proxim
promot
gregoir
et
al
cebpa
pparg
serv
key
transcript
activ
adipogenesi
promot
express
adipocytespecif
gene
lpl
gregoir
et
al
accumul
transloc
nucleu
bind
tcell
factor
tcf
lymphoidenhanc
factor
famili
transcript
factor
bennett
et
al
activ
transcript
target
gene
known
function
suppress
fu
et
al
shi
et
al
desmethylicaritin
metabolit
epimediumderiv
flavonoid
identifi
serum
oral
administr
liu
lou
shen
et
al
classifi
phytoestrogen
exert
estrogeniclik
activ
wang
lou
ye
et
al
wang
et
al
antiinflammatori
activ
chen
et
al
kim
et
al
antioxid
activ
wo
et
al
recent
estrogen
report
inhibit
adipogenesi
activ
signal
kanit
et
al
accordingli
hypothes
desmethylicaritin
may
abl
inhibit
adipogenesi
via
regul
signal
pathway
ie
relev
mechan
explain
role
epimediumderiv
flavonoid
also
potenti
use
desmethylicaritin
novel
phytochem
agent
prevent
disord
involv
lipid
metabol
desmethylicaritin
defin
chemic
structur
fig
puriti
suppli
institut
tradit
chines
medicin
natur
product
jinan
univers
guangzhou
china
cell
cultur
reagent
obtain
invitrogen
cell
prolifer
elisa
brdu
colorimetr
kit
purchas
roch
germani
primer
purchas
tech
dragon
ltd
hong
kong
rabbit
monoclon
antibodi
hrp
goat
antirabbit
igg
antibodi
obtain
abgent
san
diego
usa
actin
monoclon
antibodi
dylight
affinipur
goat
antirabbit
gg
hl
obtain
earhox
san
diego
usa
antibodi
immunofluoresc
purchas
abgent
san
diego
usa
reagent
chemic
obtain
sigmaaldrich
inc
usa
preadipocyt
purchas
atcc
american
type
cultur
collect
manassa
va
usa
cell
maintain
dulbecco
modifi
eagl
medium
dmem
fetal
bovin
serum
incub
co
cell
viabil
assess
use
mtt
assay
preadipocyt
cell
huvec
seed
cellswel
plate
h
incub
cell
treat
desmethylicaritin
concentr
h
mtt
use
obtain
percentag
viabl
cell
zhang
et
al
experi
repeat
time
induc
adipogenesi
cell
cellswel
plate
plate
maintain
day
reach
confluenc
design
day
cultur
medium
exchang
differenti
medium
dmem
contain
fb
mm
ibmx
dexamethason
insulin
indomethacin
day
cell
incub
adipocyt
growth
medium
dmem
supplement
fb
insulin
day
maintain
thereaft
fb
dmem
day
base
publish
protocol
zhang
et
al
desmethylicaritin
vehicl
dmso
ad
medium
full
cours
differenti
medium
chang
everi
day
day
cell
stain
oil
red
indic
cell
lipid
content
zhang
et
al
experi
repeat
time
confluenc
cell
treat
desmethylicaritin
day
brdu
ad
cultur
medium
concentr
brdu
label
h
medium
remov
brdu
incorpor
measur
use
cell
prolifer
elisa
kit
roch
dilut
antibrduperoxidas
conjug
antibodi
reaction
stop
h
absorb
measur
nm
total
rna
isol
use
rneasi
total
rna
extract
kit
qiagen
cat
hilden
germani
accord
manufactur
protocol
pfaffl
fluoresc
signal
emit
collect
abi
prism
sequenc
detect
system
signal
convert
numer
valu
express
cdna
measur
rel
express
housekeep
gene
compar
thresholdcycl
ct
method
describ
real
time
pcr
primer
use
experi
shown
tabl
mrna
level
gene
normal
use
intern
control
analys
perform
duplic
sampl
use
cell
three
differ
cultur
experi
repeat
time
protein
nucleu
cytoplasm
extract
separ
neper
nuclear
cytoplast
extract
reagent
kit
cell
cellsdish
grew
confluenc
dish
desmethylicaritin
ad
differenti
medium
day
cell
pellet
lyse
ripa
lysi
buffer
santa
cruz
ca
usa
pmsf
proteas
inhibitor
cocktail
sodium
orthovanad
treatment
ice
min
cell
lysat
clarifi
centrifug
min
remov
cell
debri
protein
content
measur
use
bca
protein
assay
kit
pierc
rockford
il
usa
aliquot
lysat
subject
sdspage
stack
gel
transfer
pvdf
membran
biorad
hercul
ca
usa
membran
probe
mous
monoclon
antibodi
mab
follow
horseradish
peroxidaseconjug
secondari
antibodi
dilut
visual
use
ecl
advanc
western
blot
detect
kit
amersham
uk
accord
tabl
primer
sequenc
use
realtim
pcr
revers
primer
manufactur
protocol
betaactin
use
refer
normal
differ
amount
protein
among
sampl
day
cell
fix
paraformaldehyd
permeabil
triton
antibodi
abgent
usa
appli
overnight
dylight
affinipur
goat
antirabbit
gg
hl
earthox
usa
appli
h
room
temperatur
dark
dapi
appli
min
sampl
view
leica
confoc
microscop
leica
tc
germani
quantit
data
present
mean
three
repeat
experi
statist
comparison
perform
use
spss
softwar
chicago
il
usa
oneway
analysi
varianc
anova
follow
tukey
post
hoc
test
multigroup
comparison
use
assess
statist
signific
p
chemic
structur
desmethylicaritin
shown
fig
effect
desmethylicaritin
preadipocyt
cell
summar
fig
desmethylicaritin
variou
concentr
affect
viabil
preadipocyt
cell
impli
desmethylicaritin
toxic
preadipocyt
cell
test
concentr
effect
desmethylicaritin
preadipocyt
differenti
shown
fig
desmethylicaritin
treatment
reduc
differenti
adipocyt
dosedepend
manner
effect
dose
inhibit
adipogenesi
fig
show
cell
morpholog
chang
desmethylicaritin
treatment
character
numer
lipid
droplet
adipocyt
control
cell
howev
lipid
accumul
inhibit
desmethylicaritin
consist
quantit
result
shown
fig
differ
concentr
desmethylicaritin
significantli
decreas
lipid
droplet
cell
respect
compar
adipocyt
control
po
suggest
adipogen
potenti
desmethylicaritin
shown
fig
clonal
prolifer
measur
bromodeoxyuridin
brdu
incorpor
significantli
increas
cell
induc
adipogen
medium
po
desmethylicaritin
significantli
decreas
clonal
expans
compar
induc
group
p
stimul
differenti
medium
gene
express
two
adipogen
transcript
factor
earli
phase
adiogenesi
examin
ie
cebpd
cebpb
induct
adipogenesi
abund
cebpd
mrna
reach
maximum
h
induct
adipogenesi
decreas
afterward
desmethylicaritin
show
signific
effect
mrna
express
cebpd
time
point
compar
induct
cell
fig
abund
cebpb
mrna
transient
increas
reach
maximum
h
induct
decreas
slightli
h
sustain
desmethylicaritin
signific
effect
cebpb
mrna
express
adipogen
induct
h
compar
vehicl
group
fig
compar
cell
without
adipogen
induct
cebpa
rose
significantli
adipogen
induc
cell
day
treatment
increas
sharpli
day
kept
high
level
day
stabil
thereaft
fig
desmethylicaritin
significantli
downregul
mrna
express
cebpa
time
point
day
day
day
day
p
compar
adipogen
induc
cell
without
desmethylicaritin
treatment
fig
similarli
compar
cell
without
adipogen
induct
pparg
rais
significantli
adipogen
induc
cell
day
treatment
fig
desmethylicaritin
significantli
downregul
mrna
express
pparg
time
point
except
day
day
day
day
p
compar
adipogen
induc
cell
without
desmethylicaritin
treatment
fig
order
confirm
desmethylicaritin
abl
decreas
adipogenesi
inhibit
express
cebpa
pparg
mrna
chang
express
adipocytespecif
gene
regul
cebpa
pparg
investig
adipogen
induc
cell
express
level
lpl
ie
target
gene
cebpa
pparg
increas
day
adipogenesi
induct
cebpa
pparg
express
alreadi
increas
fig
f
desmethylicaritin
significantli
downregul
mrna
express
time
point
day
day
day
day
p
compar
adipogen
cell
without
desmethylicaritin
treatment
fig
desmethylicaritin
significantli
downregul
mrna
express
lpl
time
point
except
day
day
day
day
p
compar
adipogen
cell
without
desmethylicaritin
treatment
fig
desmethylicaritin
significantli
decreas
express
level
lpl
follow
increment
cebpa
pparg
express
four
day
adipogen
induct
express
significantli
decreas
compar
cell
without
adipogen
induct
desmethylicaritin
significantli
upregul
express
day
adipogen
induct
p
fig
compar
adipogen
group
mrna
express
control
group
without
induct
significantli
lower
day
higher
day
p
yet
without
signific
differ
day
adipogen
induct
mrna
express
show
pattern
without
desmethylicaritin
treatment
fig
impli
desmethylicaritin
effect
gene
express
western
blot
analysi
use
investig
effect
desmethylicaritin
adipogenicstimul
protein
express
cell
shown
fig
cytoplasm
nuclear
rel
stronger
express
observ
control
group
adipogenicstimul
group
desmethylicaritin
recov
depress
express
induc
adipogenicstimul
cytoplasm
nuclear
fig
confoc
microscopi
show
cell
nuclei
decreas
day
adipogen
induct
desmethylicaritin
recov
nuclear
transloc
show
overlap
dapi
antibodi
observ
confoc
microscop
fig
accord
hypothesi
studi
demonstr
first
time
desmethylicaritin
metabolit
epimediumderiv
flavonoid
inhibit
adipogenesi
downregul
express
adipogen
transcript
factor
cebpa
pparg
signal
pathway
may
regul
desmethylicaritin
suppress
adipogenesi
previou
report
shown
enhanc
adipogenesi
bone
marrow
contribut
steroidinduc
osteonecorsi
rabbit
qin
et
al
report
steroid
evid
relat
control
development
program
adipocyt
differenti
vitro
adipocyt
increas
concentr
dexamethason
durat
steroid
therapi
dexamethason
directli
stimul
differenti
msc
adipocyt
acceler
lipid
format
yin
et
al
epimediumderiv
flavonoid
abl
inhibit
extravascular
lipid
deposit
steroidassoci
osteonecrosi
zhang
et
al
studi
use
preadipocyt
cell
induc
insulin
dexamethason
vitro
model
studi
convers
preadipocyt
adipocyt
explor
mechan
desmethylicaritin
bioactiv
metabolit
epimediumderiv
flavonoid
inhibit
adipogenesi
desmethylicaritin
inhibit
mrna
express
cebpa
pparg
without
affect
cebpd
cebpb
indic
might
pathway
involv
downregul
cebpa
pparg
inde
report
activ
signal
stimul
osteoblastogenesi
inhibit
adipogenesi
modul
rel
level
cell
type
specif
transcript
factor
bennett
et
al
inhibitori
signal
influenc
induct
earli
adipogen
factor
cebpd
cebpb
repress
cebpa
pparg
suggest
primari
mechan
wnt
signal
control
mesenchym
cell
fate
rosen
et
al
bennett
et
al
zhang
et
al
found
flavonoid
epimedium
exert
promot
effect
osteogen
differenti
partial
via
signal
pathway
zhang
et
al
thu
find
present
studi
confirm
hypothesi
role
desmethylicaritin
regul
signal
pathway
adipogenesi
key
factor
inhibit
adipogenesi
wnt
signal
bennett
et
al
bind
frizzl
receptor
coreceptor
lead
dishevel
phosphoryl
axin
degrad
turn
result
hypophosphoryl
accumul
cytoplasm
transloc
nucleu
bind
tcflef
transcript
factor
activ
wnt
target
gene
inhibit
adipogenesi
suppress
cebpa
pparg
bennett
et
al
christodoulid
et
al
result
show
desmethylicaritin
upregul
mrna
express
fig
western
blot
immunofluores
analysi
confirm
desmethylicaritin
abl
promot
nuclear
transloc
might
play
import
role
suppress
adipogenesi
henc
infer
desmethylicaritin
may
inhibit
adipocyt
differenti
activ
signal
pathway
result
inhibit
adipogen
transcript
factor
cebpa
pparg
christodoulid
et
al
desmethylicaritin
phytoestrogen
molecul
report
structur
function
mimic
estrogen
exert
estrogenlik
activ
wang
lou
ye
et
al
wang
et
al
addit
report
intracellular
signal
mediat
estrogen
receptor
er
receptor
wnt
signal
converg
varea
et
al
estrogen
activ
transcript
nuclei
regul
ermedi
transcript
kouzmenko
et
al
varea
et
al
therefor
biolog
evid
support
er
signal
pathway
may
also
involv
desmethylicaritin
role
inhibit
adipognesi
via
nuclear
transloc
studi
shown
flavonoid
apigenin
mohanad
et
al
resveratrol
florian
et
al
foster
ca
entri
ceramid
format
atp
deplet
erythrocyt
subsequ
trigger
suicid
erythrocyt
death
parallel
phosphatidylserin
exposur
eryptosi
bind
phosphatidylserin
receptor
macrophag
liver
kupffer
cell
engulf
degrad
affect
rbc
lang
et
al
local
phagocyt
cell
produc
activ
jnk
inflammatori
signal
pathway
regul
cellular
transcript
event
therebi
lead
greater
product
proinflammatori
mediat
jnk
pathway
feedforward
immunofluores
dapi
day
adipogen
induct
dapi
nuclear
imag
merg
right
figur
show
desmethylicaritin
increas
nucleu
mechan
glucocorticoid
end
product
hypothalamicpituitaryadren
axi
limit
product
proinflammatori
cytokin
inhibit
effect
target
tissu
zappulla
impli
flavonoid
desmethylicaritin
might
also
sustain
inflamm
key
surviv
mechan
harm
transient
physiolog
adapt
convert
chronic
patholog
state
zappulla
recent
studi
howev
shown
herb
sophora
flavescen
contain
desmethylicaritin
may
exert
antiinflammatori
effect
function
inhibitor
pathway
suppress
redoxbas
activ
pen
inactiv
also
report
desmethylicaritin
interfer
jnkmediat
cjun
phosphoryl
therebi
attenu
proinflammatori
product
chen
et
al
nonetheless
desmethylicaritin
might
also
affect
fate
erythrocyt
relat
risk
factor
diabet
obes
kristina
et
al
metabol
syndrom
increasingli
preval
condit
western
world
zappulla
sinc
human
expos
uniformli
singl
pure
chemic
rather
complex
variabl
mixtur
substanc
may
also
interact
synergist
vitro
studi
might
reliabl
justifi
prevent
everlast
use
kind
drug
includ
supplement
prenylflavonoid
deriv
therefor
synergist
effect
desmethylicaritin
chemic
environ
requir
explor
conclus
present
vitro
studi
demonstr
first
time
phytoestrogen
molecul
desmethylicaritin
uniqu
metabolit
epimediumderiv
flavonoid
inhibit
adipogenesi
downregul
express
adipogen
transcript
factor
cebpa
pparg
signal
pathway
may
regul
desmethylicaritin
suppress
adipogenesi
find
shield
light
action
mechan
desmethylicaritin
inhibit
adipogenesi
provid
scientif
rational
use
epimediumderiv
flavonoid
prevent
steroidassoci
osteonecrosi
studi
also
support
potenti
r
desmethylicaritin
novel
phytochem
agent
prevent
disord
involv
lipid
metabol
